Company
Electra
Translating Differentiated Biology into Transformational Medicines
Also known as Electra Therapeutics, Electra Therapeutics, Inc.
- Status
- Operatingas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- South San Francisco, CA, United States
- Legal name
- Electra Therapeutics, Inc.
- electra-therapeutics.com (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Grounded in rigorous science, we are advancing a portfolio of Signal Regulatory Protein (SIRP)-directed therapies designed to improve outcomes for patients with immune-mediated diseases and cancer.
Funding snapshot
- Total raised
- $267MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series C, $183M2025-10-22
Funding rounds
- Series C
- $183M2025-10-22, Company stated
- Round, 2025
- $134M2025-10-15, SEC form D sold, 19 investors
- Series B
- $84M2022-02-16, Company stated
About the company
- Status notes
- a clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer
Products
- Other
- ELA026
- Other
- ELA822
Loading relationship preview